ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
failure to respond or late response
on 13 May 2024
Last Applicant/ Owned by
101 College Street, Suite 700
Toronto
CA
M5G1L7
Serial Number
97907161 filed on 25th Apr 2023
Registration Number
N/A
Correspondent Address
Andrew D. Price
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
VIMI
Research and development of vaccines, antiviral medicines, pharmaceuticals, medications, and medical equipment for the prevention of pandemics Fundraising services for the research and development of vaccines, antiviral medicines, pharmaceuticals, medications, and medical equipment for the prevention of pandemics
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Research and development of vaccines, antiviral medicines, pharmaceuticals, medications, and medical equipment for the prevention of pandemics
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [036]
Insurance & Financial Services
Fundraising services for the research and development of vaccines, antiviral medicines, pharmaceuticals, medications, and medical equipment for the prevention of pandemics
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97907161
Mark Type
No Service Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 13th May 2024 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| 13th May 2024 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| 27th Jan 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 27th Jan 2024 | NON-FINAL ACTION E-MAILED |
| 27th Jan 2024 | NON-FINAL ACTION WRITTEN |
| 22nd Jan 2024 | ASSIGNED TO EXAMINER |
| 20th Sep 2023 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
| 20th Sep 2023 | ASSIGNED TO LIE |
| 23rd May 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| 02th May 2023 | TEAS VOLUNTARY AMENDMENT RECEIVED |